CORE LABORATORIES INC (CLB) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CLB - US21867A1051 - Common Stock
16.8 USD
+0.37 (+2.25%)
16.8 USD
0 (0%)
Overall CLB gets a fundamental rating of 5 out of 10. We evaluated CLB against 60 industry peers in the Energy Equipment & Services industry. While CLB has a great health rating, its profitability is only average at the moment. CLB has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CLB was profitable.
In the past year CLB had a positive cash flow from operations.
CLB had positive earnings in 4 of the past 5 years.
In the past 5 years CLB always reported a positive cash flow from operatings.
1.2 Ratios
CLB's Return On Assets of 5.43% is fine compared to the rest of the industry. CLB outperforms 68.33% of its industry peers.
Looking at the Return On Equity, with a value of 11.84%, CLB is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
With a decent Return On Invested Capital value of 9.29%, CLB is doing good in the industry, outperforming 71.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CLB is in line with the industry average of 7.48%.
The 3 year average ROIC (8.80%) for CLB is below the current ROIC(9.29%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROIC | 9.29% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
1.3 Margins
CLB's Profit Margin of 6.21% is in line compared to the rest of the industry. CLB outperforms 60.00% of its industry peers.
CLB's Profit Margin has declined in the last couple of years.
CLB has a Operating Margin (11.16%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CLB has declined.
The Gross Margin of CLB (19.95%) is worse than 70.00% of its industry peers.
CLB's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% |
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLB is still creating some value.
Compared to 1 year ago, CLB has about the same amount of shares outstanding.
Compared to 5 years ago, CLB has more shares outstanding
CLB has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.31 indicates that CLB is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.31, CLB belongs to the top of the industry, outperforming 81.67% of the companies in the same industry.
The Debt to FCF ratio of CLB is 3.32, which is a good value as it means it would take CLB, 3.32 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CLB (3.32) is better than 65.00% of its industry peers.
CLB has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CLB (0.42) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Altman-Z | 3.31 |
ROIC/WACC1.06
WACC8.75%
2.3 Liquidity
A Current Ratio of 2.37 indicates that CLB has no problem at all paying its short term obligations.
CLB has a Current ratio of 2.37. This is in the better half of the industry: CLB outperforms 68.33% of its industry peers.
A Quick Ratio of 1.76 indicates that CLB should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.76, CLB is doing good in the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 |
3. Growth
3.1 Past
The earnings per share for CLB have decreased by -9.41% in the last year.
CLB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.14% yearly.
Looking at the last year, CLB shows a decrease in Revenue. The Revenue has decreased by -1.02% in the last year.
Measured over the past years, CLB shows a decrease in Revenue. The Revenue has been decreasing by -4.75% on average per year.
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
3.2 Future
Based on estimates for the next years, CLB will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.78% on average per year.
The Revenue is expected to grow by 3.47% on average over the next years.
EPS Next Y-15.64%
EPS Next 2Y-2.65%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue Next Year-1.9%
Revenue Next 2Y1.16%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 21.82, the valuation of CLB can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CLB is on the same level as its industry peers.
CLB's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.34.
With a Price/Forward Earnings ratio of 20.15, CLB is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as CLB.
CLB's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.56.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.82 | ||
| Fwd PE | 20.15 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CLB is valued expensively inside the industry as 85.00% of the companies are valued cheaper.
CLB's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.75 | ||
| EV/EBITDA | 11.78 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.65%
EPS Next 3Y-0.94%
5. Dividend
5.1 Amount
CLB has a yearly dividend return of 0.24%, which is pretty low.
CLB's Dividend Yield is comparable with the industry average which is at 2.75.
Compared to an average S&P500 Dividend Yield of 2.31, CLB's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.24% |
5.2 History
The dividend of CLB decreases each year by -55.13%.
CLB has paid a dividend for at least 10 years, which is a reliable track record.
CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-55.13%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
CLB pays out 5.83% of its income as dividend. This is a sustainable payout ratio.
DP5.83%
EPS Next 2Y-2.65%
EPS Next 3Y-0.94%
16.8
+0.37 (+2.25%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)
Earnings (Next)
Inst Owners113.36%
Inst Owner Change-3.6%
Ins Owners1.02%
Ins Owner Change0.11%
Market Cap782.21M
Revenue(TTM)517.50M
Net Income(TTM)32.12M
Analysts48
Price Target15.64 (-6.9%)
Short Float %10.3%
Short Ratio8.28
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.24% |
Yearly Dividend0.04
Dividend Growth(5Y)-55.13%
DP5.83%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.26%
Min EPS beat(2)-0.33%
Max EPS beat(2)12.86%
EPS beat(4)1
Avg EPS beat(4)1.9%
Min EPS beat(4)-4.67%
Max EPS beat(4)12.86%
EPS beat(8)4
Avg EPS beat(8)4.82%
EPS beat(12)7
Avg EPS beat(12)5.16%
EPS beat(16)8
Avg EPS beat(16)3.39%
Revenue beat(2)2
Avg Revenue beat(2)0.73%
Min Revenue beat(2)0.02%
Max Revenue beat(2)1.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)1.44%
Revenue beat(8)3
Avg Revenue beat(8)-0.5%
Revenue beat(12)4
Avg Revenue beat(12)-1.2%
Revenue beat(16)5
Avg Revenue beat(16)-1.06%
PT rev (1m)0%
PT rev (3m)11.51%
EPS NQ rev (1m)1.8%
EPS NQ rev (3m)3.66%
EPS NY rev (1m)-2%
EPS NY rev (3m)-1.56%
Revenue NQ rev (1m)1.96%
Revenue NQ rev (3m)1.98%
Revenue NY rev (1m)0.83%
Revenue NY rev (3m)1.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.82 | ||
| Fwd PE | 20.15 | ||
| P/S | 1.51 | ||
| P/FCF | 22.75 | ||
| P/OCF | 15.74 | ||
| P/B | 2.88 | ||
| P/tB | 4.73 | ||
| EV/EBITDA | 11.78 |
EPS(TTM)0.77
EY4.58%
EPS(NY)0.83
Fwd EY4.96%
FCF(TTM)0.74
FCFY4.4%
OCF(TTM)1.07
OCFY6.35%
SpS11.11
BVpS5.83
TBVpS3.55
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROCE | 11.66% | ||
| ROIC | 9.29% | ||
| ROICexc | 9.8% | ||
| ROICexgc | 12.66% | ||
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% | ||
| FCFM | 6.64% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
ROICexc(3y)9.11%
ROICexc(5y)8.99%
ROICexgc(3y)11.75%
ROICexgc(5y)11.63%
ROCE(3y)11.03%
ROCE(5y)10.9%
ROICexgc growth 3Y11.32%
ROICexgc growth 5Y-6.37%
ROICexc growth 3Y11.52%
ROICexc growth 5Y-2.86%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
F-Score7
Asset Turnover0.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Debt/EBITDA | 1.58 | ||
| Cap/Depr | 104.6% | ||
| Cap/Sales | 2.96% | ||
| Interest Coverage | 6.66 | ||
| Cash Conversion | 68.62% | ||
| Profit Quality | 107.03% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 | ||
| Altman-Z | 3.31 |
F-Score7
WACC8.75%
ROIC/WACC1.06
Cap/Depr(3y)71.15%
Cap/Depr(5y)68.67%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.39%
Profit Quality(3y)84.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
EPS Next Y-15.64%
EPS Next 2Y-2.65%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
Revenue Next Year-1.9%
Revenue Next 2Y1.16%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
EBIT growth 1Y-6.83%
EBIT growth 3Y11.62%
EBIT growth 5Y-8.87%
EBIT Next Year10.41%
EBIT Next 3Y4.07%
EBIT Next 5Y17.46%
FCF growth 1Y286.32%
FCF growth 3Y23.36%
FCF growth 5Y-8.39%
OCF growth 1Y165.78%
OCF growth 3Y15.5%
OCF growth 5Y-8.83%
CORE LABORATORIES INC / CLB FAQ
Can you provide the ChartMill fundamental rating for CORE LABORATORIES INC?
ChartMill assigns a fundamental rating of 5 / 10 to CLB.
What is the valuation status for CLB stock?
ChartMill assigns a valuation rating of 2 / 10 to CORE LABORATORIES INC (CLB). This can be considered as Overvalued.
Can you provide the profitability details for CORE LABORATORIES INC?
CORE LABORATORIES INC (CLB) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for CLB stock?
The Price/Earnings (PE) ratio for CORE LABORATORIES INC (CLB) is 21.82 and the Price/Book (PB) ratio is 2.88.
Can you provide the financial health for CLB stock?
The financial health rating of CORE LABORATORIES INC (CLB) is 7 / 10.